Is SS-31 FDA approved? No — elamipretide remains an investigational peptide with no FDA approval for any human use. Here's what the FDA status means.
No. SS-31 is not FDA-approved for human use in the United States. The peptide, better known as elamipretide, is an investigational compound that has been tested in clinical trials for rare mitochondrial diseases, but the FDA has never granted it marketing approval for any condition. Anything sold as SS-31 in the US is a laboratory research chemical, not an approved medicine.
What Is SS-31 (Elamipretide)?
SS-31 is a synthetic tetrapeptide designed to concentrate inside mitochondria, the energy-producing structures in your cells. Researchers study it because it binds to cardiolipin, a lipid on the inner mitochondrial membrane, and appears to stabilize mitochondrial function in laboratory and animal models.
In the scientific literature the ss 31 peptide goes by several names: elamipretide, MTP-131, and Bendavia. It has been investigated in small human trials for:
- Barth syndrome, a rare genetic disorder that affects mitochondria
- Primary mitochondrial myopathy
- Leber hereditary optic neuropathy
- Heart failure and dry age-related macular degeneration
Those studies are why SS-31 appears in search results alongside approved peptides, even though its regulatory status is completely different.
SS-31 FDA Approval Status: The Short Answer
SS-31 has not been approved by the FDA for any medical condition. It is an investigational drug, which means it can only be given to humans as part of authorized clinical research.
Elamipretide has received several FDA designations, and these are frequently confused with approval:
- Orphan drug designation for Barth syndrome
- Fast track designation for certain rare mitochondrial diseases
- Rare pediatric disease designation
An FDA designation is not an FDA approval. Orphan drug status offers incentives such as tax credits and market exclusivity if a drug is eventually approved; it does not mean the agency has determined the drug is safe and effective.
In 2024, an FDA advisory committee reviewed elamipretide for Barth syndrome and did not recommend approval, citing limited evidence of benefit. That outcome keeps SS-31 firmly on the investigational side of the line.
How SS-31 Compares With Other Peptides and Drugs
Most of the confusion around SS-31 comes from lumping it together with compounds that are already approved. The table below shows how different the regulatory picture can look.
| Compound | Typical use | FDA status |
|---|---|---|
| SS-31 (elamipretide) | Investigational mitochondrial therapy | Not approved; research only |
| Semaglutide | Type 2 diabetes, chronic weight management | Approved (Ozempic, Wegovy, Rybelsus) |
| Bremelanotide (PT-141) | Hypoactive sexual desire disorder | Approved for premenopausal women (Vyleesi) |
| CJC-1295 / ipamorelin | Growth hormone research | Not approved; research only |
If you are asking is semaglutide fda-approved, the answer is yes — it holds approvals for diabetes and for chronic weight management. Readers also ask is pt 141 fda approved for men, and the answer there is no: bremelanotide is approved only for premenopausal women with hypoactive sexual desire disorder.
Growth hormone secretagogues sit on the unapproved side as well. A search for CJC-1295 and ipamorelin approval status returns the same conclusion: neither peptide is FDA-approved for human use in the United States.
Why People Search for SS-31 Dosing and Reconstitution
Because SS-31 is not approved, there is no FDA-approved dose, no approved formulation, and no approved route of administration. Human exposure has occurred only inside clinical trials, where researchers set the doses and administered them under medical supervision.
That has not stopped online vendors from publishing ss-31 reconstitution and dosage guides. These guides describe handling a lyophilized powder with bacteriostatic water, but they are written for laboratory work, not for people.
Most dosing schedules circulating online trace back to animal studies, where researchers used a range of amounts and frequencies. Animal results do not translate directly into human doses, and no human dosing schedule has been validated outside a clinical trial setting.
Another common research question involves stacking. Discussion of ss-31 and mots-c together comes from cell and animal work on mitochondrial function, but there is no human trial data on combining the two, and no approved product exists for either compound.
Safety and Quality Concerns With Research-Grade SS-31
Peptides sold "for research use only" are not held to the manufacturing, purity, or sterility standards required of approved drugs. Independent testing has repeatedly found that research peptides can be underdosed, mislabeled, or contaminated.
Because SS-31 has not completed FDA review, its full safety profile in humans is unknown. Reported side effects in trials have generally been mild, but a limited trial population cannot reveal rare or long-term risks.
Anyone considering an unapproved peptide for a health condition should talk with a licensed healthcare professional first. A clinician can explain approved alternatives and help you avoid products that have never been evaluated for human use.
Bottom Line on SS-31 FDA Approval
SS-31, or elamipretide, is an investigational peptide and does not have FDA approval for any indication. FDA designations such as orphan drug and fast track status are incentives for development, not evidence of approval.
If a vendor claims that SS-31 is FDA-approved, that claim is false. Legitimate SS-31 material is sold only as a research chemical and is labeled as not for human consumption.
Frequently Asked Questions
Is SS-31 approved by the FDA?
No. SS-31, also called elamipretide, is not FDA-approved for any human use. It has been studied in clinical trials for rare mitochondrial conditions, but it has never received marketing approval from the agency.
Is SS-31 the same thing as elamipretide?
Yes. SS-31, elamipretide, MTP-131, and Bendavia all refer to the same synthetic tetrapeptide. Elamipretide is the international nonproprietary name used in clinical research and regulatory filings.
Can you buy SS-31 legally in the US?
SS-31 can legally be sold as a laboratory research chemical, but it cannot legally be sold as a drug or dietary supplement for human consumption. Products marketed for human use without FDA approval violate federal law, and their purity is not verified by any regulator.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.